Table 1 Pharmacological and molecular properties of salidroside
From: Mechanism of salidroside against coronary artery disease by network pharmacology analysis
Name | MW | AlogP | Hdon | Hacc | OB (%) | Caco-2 | BBB | DL | FASA | TPSA | RBN |
|---|---|---|---|---|---|---|---|---|---|---|---|
Salidroside | 300.34 | -0.47 | 5 | 7 | 7.01 | -0.82 | -1.41 | 0.2 | 119.61 | 0.3 | 5 |